BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3289878)

  • 1. [Dipyridamole-201thallium perfusion scintigraphy in coronary diseases].
    Nienaber CA; Spielmann RP
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1029-33. PubMed ID: 3289878
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipyridamole thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy.
    Beller GA
    J Am Coll Cardiol; 1989 Dec; 14(7):1642-4. PubMed ID: 2584552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dipyridamole thallium-201 myocardial scintigraphy in coronary diagnosis; a comparison of methods with thallium-201 myocardial scintigraphy after ergometer stress].
    Neuzner J; Kornecki P; Kremer P; Grebe S; Schlepper M
    Z Kardiol; 1987 Dec; 76(12):737-43. PubMed ID: 3439248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of serious hemodynamic changes in physically-limited patients following oral dipyridamole challenge before thallium-201 scintigraphy.
    Kahn D; Argenyi EA; Berbaum K; Rezai K
    Clin Nucl Med; 1990 Oct; 15(10):678-82. PubMed ID: 2225669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of thallium-201 myocardial kinetics during dipyridamole loading and exercise stress in coronary artery disease].
    Tsuda T; Kodera K; Yamamoto T; Hayashi S; Shibata A; Ogawa S
    Kaku Igaku; 1987 Sep; 24(9):1393-8. PubMed ID: 3437582
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine and dipyridamole myocardial scintigraphy.
    Iskandrian AS; Heo J
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):73-81. PubMed ID: 1450250
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined intravenous dipyridamole and symptom-related stress testing.
    Druck MN; Taylor A; Bouchard G; Katz J
    J Nucl Med; 1994 Dec; 35(12):2055. PubMed ID: 7989993
    [No Abstract]   [Full Text] [Related]  

  • 8. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise.
    Lee J; Chae SC; Lee K; Heo J; Iskandrian AS
    J Nucl Med; 1994 Apr; 35(4):535-41. PubMed ID: 8151371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.
    Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP
    J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise supplementation of dipyridamole for myocardial perfusion imaging.
    DePuey EG
    J Nucl Med; 1991 Aug; 32(8):1564-8. PubMed ID: 1869980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of serum drug level following a single oral dose of dipyridamole.
    Segall GM; Davis MJ
    J Nucl Med; 1988 Oct; 29(10):1662-7. PubMed ID: 3171696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenosine triphosphate loading thallium-201 myocardial scintigraphy: optimal dose and diagnostic accuracy].
    Yonezawa Y; Yoshikawa J; Shakudo M; Okumachi F; Shiratori K; Koizumi K; Akasaka T; Yoshida K; Ikekubo K
    J Cardiol; 1995 Jan; 25(1):9-13. PubMed ID: 7877104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventional testing for myocardial perfusion: a new application for adenosine.
    McNulty SA
    Cardiovasc Nurs; 1992; 28(4):24-8. PubMed ID: 1606589
    [No Abstract]   [Full Text] [Related]  

  • 14. Thallium-201 scanning: some pharmacologic interventions.
    Blend MJ
    J Am Osteopath Assoc; 1987 Dec; 87(12):816-24. PubMed ID: 3323148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thallium-201 myocardial scintigraphy on coronary vasodilator, dipyridamole: assessment of regional coronary perfusion reserve (author's transl)].
    Futatsuya R; Seto H; Kakishita M; Kamei T; Terada Y; Sugimoto T
    Kaku Igaku; 1981 Nov; 18(9):1287-94. PubMed ID: 7339102
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe ischemic ventricular arrhythmia during dipyridamole scintigraphy].
    Egloff P; Douard H; Barat JL; Broustet JP
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):861-3. PubMed ID: 1898221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scintigraphy of myocardial perfusion combined with pharmacologic stress with dipyridamole].
    Chalela WA; Cruz SH; Moraes AP; Soares JĂșnior J; Giorgi MC; Izaki M; Moffa PJ; Cerri GG; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1993 Oct; 61(4):207-11. PubMed ID: 8154998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative thallium myocardial tomoscintigraphy. Value of intravenous infusion of dipyridamole after negative submaximal exercise test].
    Levy M; Pornin M; Languillat N; Charles JP; Angelard T; Sarkhis A; Bayet G; Guize L; Paillard M; Ourbak P
    Arch Mal Coeur Vaiss; 1992 Feb; 85(2):187-91. PubMed ID: 1562221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart disease.
    Younis LT; Chaitman BR
    Clin Cardiol; 1990 Jan; 13(1):3-10. PubMed ID: 2404645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of oral dipyridamole in patients undergoing thallium 201 myocardial imaging.
    Stringer KA; Branconi JM; Abadier R; Wilton JH; Royal SH
    Pharmacotherapy; 1992; 12(2):83-7. PubMed ID: 1570231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.